On Monday, ATAI Life Sciences N.V. (NASDAQ: ATAI) was 7.02% up from the session before settling in for the closing price of $1.14. A 52-week range for ATAI has been $1.02 – $2.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -16.02% over the past five years. When this article was written, the company’s average yearly earnings per share was at -222.86%. With a float of $117.07 million, this company’s outstanding shares have now reached $166.03 million.
Let’s look at the performance matrix of the company that is accounted for 83 employees. In terms of profitability, gross margin is 10.05%, operating margin of -29129.37%, and the pretax margin is -15241.27%.
ATAI Life Sciences N.V. (ATAI) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward ATAI Life Sciences N.V. stocks. The insider ownership of ATAI Life Sciences N.V. is 30.23%, while institutional ownership is 7.42%. The most recent insider transaction that took place on Sep 26 ’24, was worth 16,093,000. In this transaction 10% Owner of this company sold 2,660,000 shares at a rate of $6.05, taking the stock ownership to the 6,905,774 shares. Before that another transaction happened on May 16 ’24, when Company’s See Remarks sold 151,303 for $1.92, making the entire transaction worth $290,502. This insider now owns 328,697 shares in total.
ATAI Life Sciences N.V. (ATAI) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted 0.25 earnings per share (EPS) during the time that was better than consensus figure (set at -0.2) by 0.45. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -222.86% per share during the next fiscal year.
ATAI Life Sciences N.V. (NASDAQ: ATAI) Trading Performance Indicators
You can see what ATAI Life Sciences N.V. (ATAI) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.68. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 538.73.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.36, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.68 in one year’s time.
Technical Analysis of ATAI Life Sciences N.V. (ATAI)
ATAI Life Sciences N.V. (NASDAQ: ATAI) saw its 5-day average volume 0.67 million, a negative change from its year-to-date volume of 1.11 million. As of the previous 9 days, the stock’s Stochastic %D was 30.34%. Additionally, its Average True Range was 0.09.
During the past 100 days, ATAI Life Sciences N.V.’s (ATAI) raw stochastic average was set at 28.36%, which indicates a significant decrease from 57.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 80.61% in the past 14 days, which was higher than the 60.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2096, while its 200-day Moving Average is $1.5961. Nevertheless, the first resistance level for the watch stands at $1.2467 in the near term. At $1.2733, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.3267. If the price goes on to break the first support level at $1.1667, it is likely to go to the next support level at $1.1133. Assuming the price breaks the second support level, the third support level stands at $1.0867.
ATAI Life Sciences N.V. (NASDAQ: ATAI) Key Stats
There are 167,406K outstanding shares of the company, which has a market capitalization of 204.72 million. As of now, sales total 310 K while income totals -40,220 K. Its latest quarter income was 270 K while its last quarter net income were -57,310 K.
